(Q43889817)

27 November 2017

title

Mediators of inflammation in children with type I diabetes mellitus: cytokines in type I diabetic children (English)

1 reference

27 November 2017

0 references

0 references

Erbağci AB

1

1 reference

27 November 2017

Tarakçioğlu M

2

1 reference

27 November 2017

Coşkun Y

3

1 reference

27 November 2017

Sivasli E

4

1 reference

27 November 2017

Sibel Namiduru E

5

1 reference

27 November 2017

publication date

1 November 2001

1 reference

27 November 2017

published in

Clinical Biochemistry

1 reference

27 November 2017

volume

34

1 reference

27 November 2017

issue

8

1 reference

27 November 2017

page(s)

645-650

1 reference

Immunogenetics of insulin-dependent diabetes mellitus.

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900275-2

Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900275-2

TNF-alpha and insulin resistance: summary and future prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900275-2

Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900275-2

Beta-cell ontogeny: growth and death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900275-2

Elevated fibrinogen and the relation to acute phase response in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900275-2

Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900275-2

Soluble tumor necrosis factor receptors in sera from patients with insulin-dependent diabetes mellitus: relations to duration and complications of disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900275-2

Cytokine secretion is impaired in women with diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900275-2

Cytokine secretion patterns in twins discordant for Type I diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900275-2

Interleukin 1 beta, tumour necrosis factor-alpha and interleukin 1 receptor antagonist in newly diagnosed insulin-dependent diabetes mellitus: comparison to long-standing diabetes and healthy individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900275-2

Interleukin-1-beta, tumor necrosis factor-alpha, insulin secretion and oral glucose tolerance in non-diabetic siblings of children with IDDM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900275-2

Significance of chemokines and activated platelets in patients with diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900275-2

Interleukin-8 production in human adipose tissue. inhibitory effects of anti-diabetic compounds, the thiazolidinedione ciglitazone and the biguanide metformin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900275-2

Chemokines control fat accumulation and leptin secretion by cultured human adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900275-2

Diabetes-induced impairment of macrophage cytokine release in a rat model: potential role of serum lipids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900275-2

Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900275-2

RAGE: a novel cellular receptor for advanced glycation end products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900275-2

Decreased in vitro IL-4 [corrected] and IL-10 production by peripheral blood in first degree relatives at high risk of diabetes type-I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900275-2

Activated T lymphocytes from patients with high risk of type I diabetes mellitus have different ability to produce interferon-gamma, interleukin-6 and interleukin-10 and undergo anti-CD95 induced apoptosis after insulin stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900275-2

Decreased secretion of Th2 cytokines precedes Up-regulated and delayed secretion of Th1 cytokines in activated peripheral blood mononuclear cells from patients with insulin-dependent diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900275-2

Dysregulation of in vitro cytokine production by monocytes during sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900275-2

Dissociation between plasma and monocyte-associated cytokines during sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900275-2

IL-6 and APPs: anti-inflammatory and immunosuppressive mediators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900275-2

IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900275-2

10.1016/S0009-9120(01)00275-2

7 January 2021

Identifiers

DOI

1 reference

27 November 2017

1 reference